Advanced Search
  • Jun 20, 2024
    Vercise™ Neural Navigator 5 with STIMVIEW™ XT technology is designed to streamline procedure for people living with neurological conditions

    HEMEL HEMPSTEAD, United Kingdom – 20 June 2024 – Boston Scientific Corporation (NYSE: BSX) has obtained CE Mark on the Vercise™ Neural Navigator 5 Software with STIMVIEW™ XT technology,...

  • Jan 8, 2024
    Acquisition to expand urology portfolio with differentiated technologies to treat urinary and bowel dysfunction

    Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Axonics, Inc. (Nasdaq: AXNX), a publicly traded medical technology company primarily...

  • Dec 12, 2023
    New virtual power purchase agreement helps to advance the company’s decarbonisation goals on its path to net zero

    MADRID, SPAIN, 12 December 2023 – Boston Scientific Corporation (NYSE: BSX) has activated its first European virtual power purchase agreement (VPPA) with leading renewable energy developer and solutions provider BayWa r.e., helping the company make progress on its decarbonisation targets.

  • Sep 5, 2023
    Research conducted in the United Kingdom for pain awareness month points to a gender difference in the experience of chronic pain, pursuing pain relief and the feeling of being understood

    HEMEL HEMPSTEAD, United Kingdom – 5 Sept. 2023 – Boston Scientific (NYSE: BSX) today revealed survey results of 2,000 people living with chronic pain in the United Kingdom (UK) that unveiled...

  • May 18, 2023
    Taoiseach Leo Varadkar joins company’s 25-year anniversary celebrations in Clonmel

    Taoiseach Leo Varadkar joins company’s 25-year anniversary celebrations in Clonmel CLONMEL, IRELAND (19 May 2023) - Boston Scientific Corporation (NYSE: BSX) will today announce an €80 million...

Show 5102550100 per page
Top